David N. Gordon, Chief Medical Officer at Aclaris Therapeutics, Inc. (ACRS), sold 65,914 shares at $22.71 ($1.5M) on 2021-06-01, disclosed to the SEC on 2021-06-02.
Open-market sale of $1.5M ACRS by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.71 | 9,115 | $207K | 14.1% |
| 2 | $22.71 | 9,115 | $207K | 14.1% |
| 3 | $23.57 | 4,885 | $115K | 7.9% |
| 4 | $23.57 | 4,885 | $115K | 7.9% |
| 5 | $21.50 | 31,114 | $669K | 45.7% |
| 6 | $22.26 | 6,800 |
| $151K |
| 10.3% |
| Total | $22.22 avg | 65,914 | $1.5M | 100% |